GO:0016363 | nuclear matrix | 1.95e-06 | 1.91e-02 | 5.363 | 4 | 7 | 73 |
GO:0010467 | gene expression | 3.24e-05 | 3.17e-01 | 3.075 | 6 | 31 | 535 |
GO:0000812 | Swr1 complex | 3.42e-05 | 3.34e-01 | 7.746 | 2 | 2 | 7 |
GO:0016020 | membrane | 3.86e-05 | 3.77e-01 | 2.316 | 8 | 38 | 1207 |
GO:0005730 | nucleolus | 4.10e-05 | 4.01e-01 | 2.304 | 8 | 41 | 1217 |
GO:0031011 | Ino80 complex | 4.56e-05 | 4.45e-01 | 7.553 | 2 | 2 | 8 |
GO:0005654 | nucleoplasm | 4.83e-05 | 4.72e-01 | 2.586 | 7 | 55 | 876 |
GO:0043968 | histone H2A acetylation | 7.32e-05 | 7.15e-01 | 7.231 | 2 | 2 | 10 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.07e-04 | 1.00e+00 | 6.968 | 2 | 3 | 12 |
GO:0003678 | DNA helicase activity | 2.47e-04 | 1.00e+00 | 6.383 | 2 | 3 | 18 |
GO:0071339 | MLL1 complex | 2.47e-04 | 1.00e+00 | 6.383 | 2 | 2 | 18 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.19e-04 | 1.00e+00 | 4.424 | 3 | 18 | 105 |
GO:0070062 | extracellular vesicular exosome | 3.62e-04 | 1.00e+00 | 1.873 | 8 | 43 | 1641 |
GO:0043967 | histone H4 acetylation | 3.72e-04 | 1.00e+00 | 6.094 | 2 | 2 | 22 |
GO:0000398 | mRNA splicing, via spliceosome | 5.72e-04 | 1.00e+00 | 4.138 | 3 | 8 | 128 |
GO:0005829 | cytosol | 6.63e-04 | 1.00e+00 | 1.750 | 8 | 58 | 1787 |
GO:0015030 | Cajal body | 7.93e-04 | 1.00e+00 | 5.553 | 2 | 2 | 32 |
GO:0040008 | regulation of growth | 1.06e-03 | 1.00e+00 | 5.344 | 2 | 2 | 37 |
GO:0032508 | DNA duplex unwinding | 1.12e-03 | 1.00e+00 | 5.305 | 2 | 5 | 38 |
GO:0008380 | RNA splicing | 1.20e-03 | 1.00e+00 | 3.772 | 3 | 7 | 165 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.30e-03 | 1.00e+00 | 5.195 | 2 | 16 | 41 |
GO:1990259 | histone-glutamine methyltransferase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004832 | valine-tRNA ligase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0008295 | spermidine biosynthetic process | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004766 | spermidine synthase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0005634 | nucleus | 1.60e-03 | 1.00e+00 | 1.210 | 10 | 67 | 3246 |
GO:0000502 | proteasome complex | 1.71e-03 | 1.00e+00 | 4.998 | 2 | 17 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.86e-03 | 1.00e+00 | 4.938 | 2 | 3 | 49 |
GO:0006310 | DNA recombination | 1.93e-03 | 1.00e+00 | 4.909 | 2 | 6 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.09e-03 | 1.00e+00 | 4.853 | 2 | 17 | 52 |
GO:0006281 | DNA repair | 2.17e-03 | 1.00e+00 | 3.473 | 3 | 19 | 203 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.17e-03 | 1.00e+00 | 4.825 | 2 | 17 | 53 |
GO:0005681 | spliceosomal complex | 2.33e-03 | 1.00e+00 | 4.772 | 2 | 2 | 55 |
GO:0043234 | protein complex | 2.39e-03 | 1.00e+00 | 3.424 | 3 | 8 | 210 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.42e-03 | 1.00e+00 | 4.746 | 2 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.51e-03 | 1.00e+00 | 4.720 | 2 | 16 | 57 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.77e-03 | 1.00e+00 | 4.646 | 2 | 17 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 2.86e-03 | 1.00e+00 | 4.622 | 2 | 5 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.86e-03 | 1.00e+00 | 4.622 | 2 | 16 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.25e-03 | 1.00e+00 | 4.531 | 2 | 17 | 65 |
GO:0006325 | chromatin organization | 3.75e-03 | 1.00e+00 | 4.424 | 2 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.75e-03 | 1.00e+00 | 4.424 | 2 | 16 | 70 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0001652 | granular component | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0031428 | box C/D snoRNP complex | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0001649 | osteoblast differentiation | 4.19e-03 | 1.00e+00 | 4.344 | 2 | 2 | 74 |
GO:0030529 | ribonucleoprotein complex | 5.12e-03 | 1.00e+00 | 4.195 | 2 | 4 | 82 |
GO:0051414 | response to cortisol | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0000209 | protein polyubiquitination | 6.40e-03 | 1.00e+00 | 4.029 | 2 | 16 | 92 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0014075 | response to amine | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0000278 | mitotic cell cycle | 7.41e-03 | 1.00e+00 | 2.843 | 3 | 35 | 314 |
GO:0016887 | ATPase activity | 7.52e-03 | 1.00e+00 | 3.909 | 2 | 6 | 100 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0042981 | regulation of apoptotic process | 9.36e-03 | 1.00e+00 | 3.746 | 2 | 18 | 112 |
GO:0042802 | identical protein binding | 1.03e-02 | 1.00e+00 | 2.670 | 3 | 7 | 354 |
GO:0003924 | GTPase activity | 1.05e-02 | 1.00e+00 | 3.658 | 2 | 3 | 119 |
GO:0006450 | regulation of translational fidelity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 2 | 8 |
GO:0006595 | polyamine metabolic process | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.16e-02 | 1.00e+00 | 3.587 | 2 | 24 | 125 |
GO:0008266 | poly(U) RNA binding | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0006184 | GTP catabolic process | 1.25e-02 | 1.00e+00 | 3.531 | 2 | 3 | 130 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 10 |
GO:0005838 | proteasome regulatory particle | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0007020 | microtubule nucleation | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 2 | 11 |
GO:0030234 | enzyme regulator activity | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0071392 | cellular response to estradiol stimulus | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0060749 | mammary gland alveolus development | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0016032 | viral process | 1.72e-02 | 1.00e+00 | 2.396 | 3 | 32 | 428 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0010243 | response to organonitrogen compound | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 14 |
GO:0042176 | regulation of protein catabolic process | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0022624 | proteasome accessory complex | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 7 | 14 |
GO:0016071 | mRNA metabolic process | 2.07e-02 | 1.00e+00 | 3.144 | 2 | 21 | 170 |
GO:0044281 | small molecule metabolic process | 2.10e-02 | 1.00e+00 | 1.832 | 4 | 32 | 844 |
GO:0005719 | nuclear euchromatin | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0005839 | proteasome core complex | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 9 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 17 |
GO:0004298 | threonine-type endopeptidase activity | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 9 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 18 |
GO:0033574 | response to testosterone | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 18 |
GO:0016070 | RNA metabolic process | 2.50e-02 | 1.00e+00 | 2.998 | 2 | 21 | 188 |
GO:0005524 | ATP binding | 2.53e-02 | 1.00e+00 | 1.752 | 4 | 23 | 892 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0005525 | GTP binding | 2.73e-02 | 1.00e+00 | 2.931 | 2 | 5 | 197 |
GO:0017144 | drug metabolic process | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 21 |
GO:0030331 | estrogen receptor binding | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 25 |
GO:0008033 | tRNA processing | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 2 | 27 |
GO:0034644 | cellular response to UV | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 1 | 29 |
GO:0018107 | peptidyl-threonine phosphorylation | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 2 | 29 |
GO:0043195 | terminal bouton | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 1 | 31 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 2.605 | 2 | 11 | 247 |
GO:0007595 | lactation | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 2 | 32 |
GO:0014070 | response to organic cyclic compound | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 36 |
GO:0035690 | cellular response to drug | 4.95e-02 | 1.00e+00 | 4.305 | 1 | 2 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 2 | 40 |
GO:0042995 | cell projection | 5.33e-02 | 1.00e+00 | 4.195 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 5.33e-02 | 1.00e+00 | 4.195 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 5.71e-02 | 1.00e+00 | 4.094 | 1 | 2 | 44 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 5 | 48 |
GO:0006334 | nucleosome assembly | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 5 | 51 |
GO:0043066 | negative regulation of apoptotic process | 6.65e-02 | 1.00e+00 | 2.222 | 2 | 20 | 322 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.71e-02 | 1.00e+00 | 3.853 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 9 | 53 |
GO:0006338 | chromatin remodeling | 7.08e-02 | 1.00e+00 | 3.772 | 1 | 2 | 55 |
GO:0007565 | female pregnancy | 8.20e-02 | 1.00e+00 | 3.553 | 1 | 2 | 64 |
GO:0044822 | poly(A) RNA binding | 8.42e-02 | 1.00e+00 | 1.496 | 3 | 25 | 799 |
GO:0006364 | rRNA processing | 8.57e-02 | 1.00e+00 | 3.487 | 1 | 4 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 2 | 68 |
GO:0051082 | unfolded protein binding | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 4 | 70 |
GO:0001889 | liver development | 9.06e-02 | 1.00e+00 | 3.403 | 1 | 1 | 71 |
GO:0005815 | microtubule organizing center | 9.79e-02 | 1.00e+00 | 3.286 | 1 | 1 | 77 |
GO:0006915 | apoptotic process | 1.02e-01 | 1.00e+00 | 1.870 | 2 | 21 | 411 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 5 | 97 |
GO:0006457 | protein folding | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 4 | 97 |
GO:0005515 | protein binding | 1.30e-01 | 1.00e+00 | 0.543 | 8 | 76 | 4124 |
GO:0007507 | heart development | 1.32e-01 | 1.00e+00 | 2.825 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 1.32e-01 | 1.00e+00 | 2.825 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 2 | 110 |
GO:0016607 | nuclear speck | 1.51e-01 | 1.00e+00 | 2.622 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 1.54e-01 | 1.00e+00 | 2.587 | 1 | 2 | 125 |
GO:0006351 | transcription, DNA-templated | 1.66e-01 | 1.00e+00 | 1.066 | 3 | 9 | 1076 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.73e-01 | 1.00e+00 | 2.403 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.77e-01 | 1.00e+00 | 2.373 | 1 | 1 | 145 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 4 | 161 |
GO:0007067 | mitotic nuclear division | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 8 | 165 |
GO:0007283 | spermatogenesis | 2.02e-01 | 1.00e+00 | 2.161 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 2.05e-01 | 1.00e+00 | 2.135 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 2.11e-01 | 1.00e+00 | 2.094 | 1 | 6 | 176 |
GO:0005739 | mitochondrion | 2.17e-01 | 1.00e+00 | 1.189 | 2 | 11 | 659 |
GO:0005743 | mitochondrial inner membrane | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 3 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 1 | 203 |
GO:0019899 | enzyme binding | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 4 | 210 |
GO:0005813 | centrosome | 2.53e-01 | 1.00e+00 | 1.791 | 1 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 2.54e-01 | 1.00e+00 | 1.785 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 2.56e-01 | 1.00e+00 | 1.778 | 1 | 8 | 219 |
GO:0005737 | cytoplasm | 2.58e-01 | 1.00e+00 | 0.512 | 5 | 50 | 2633 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.49e-01 | 1.00e+00 | 1.245 | 1 | 7 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.139 | 1 | 6 | 341 |
GO:0005794 | Golgi apparatus | 4.32e-01 | 1.00e+00 | 0.856 | 1 | 5 | 415 |
GO:0042803 | protein homodimerization activity | 4.42e-01 | 1.00e+00 | 0.811 | 1 | 5 | 428 |
GO:0045087 | innate immune response | 4.60e-01 | 1.00e+00 | 0.733 | 1 | 7 | 452 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 8 | 644 |
GO:0008270 | zinc ion binding | 6.34e-01 | 1.00e+00 | 0.047 | 1 | 7 | 727 |
GO:0003677 | DNA binding | 7.35e-01 | 1.00e+00 | -0.334 | 1 | 18 | 947 |